Related Experiment Video
Updated: Feb 13, 2026

The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2
Rachel E Miller1, Shingo Ishihara1, Phuong B Tran1
1Department of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Abstract:
Pain is the predominant symptom of osteoarthritis, but the connection between joint damage and the genesis of pain is not well understood. Loss of articular cartilage is a hallmark of osteoarthritis, and it occurs through enzymatic degradation of aggrecan by cleavage mediated by a disintegrin and metalloproteinase with thrombospondin motif 4 (ADAMTS-4) or ADAMTS-5 in the interglobular domain (E373-374A). Further cleavage by MMPs (N341-342F) releases a 32-amino-acid aggrecan fragment (32-mer). We investigated the role of this 32-mer in driving joint pain. We found that the 32-mer excites dorsal root ganglion nociceptive neurons, both in culture and in intact explants. Treatment of cultured sensory neurons with the 32-mer induced expression of the proalgesic chemokine CCL2. These effects were mediated through TLR2, which we demonstrated was expressed by nociceptive neurons. In addition, intra-articular injection of the 32-mer fragment provoked knee hyperalgesia in WT but not Tlr2-null mice. Blocking the production or action of the 32-mer in transgenic mice prevented the development of knee hyperalgesia in a murine model of osteoarthritis. These findings suggest that the aggrecan 32-mer fragment directly activates TLR2 on joint nociceptors and is an important mediator of the development of osteoarthritis-associated joint pain.
Insights
Osteoarthritis pain is linked to a specific aggrecan fragment (32-mer). This fragment activates pain-sensing neurons via TLR2, driving joint pain and hyperalgesia in osteoarthritis models.
Area of Science:
- Biochemistry
- Neuroscience
- Immunology
Background:
- Osteoarthritis (OA) pain is a primary symptom, but its link to joint damage remains unclear.
- Articular cartilage degradation in OA involves aggrecan cleavage by ADAMTS-4/5 and MMPs, releasing a 32-amino-acid fragment (32-mer).
Purpose of the Study:
- To investigate the role of the aggrecan 32-mer fragment in the development of osteoarthritis-associated joint pain.
- To elucidate the mechanism by which the 32-mer fragment contributes to OA pain.
Main Methods:
- Cultured dorsal root ganglion (DRG) nociceptive neurons and intact explants were used to assess neuronal excitation by the 32-mer.
- Expression of Toll-like receptor 2 (TLR2) on nociceptive neurons was confirmed.
- Intra-articular injections of the 32-mer were performed in wild-type (WT) and Tlr2-null mice to evaluate hyperalgesia.
- Blocking 32-mer production or action in transgenic mice assessed its role in an OA model.
Main Results:
- The 32-mer fragment was found to excite DRG nociceptive neurons in vitro and in explants.
- Treatment with the 32-mer induced CCL2 expression in sensory neurons, mediated via TLR2.
- Intra-articular injection of the 32-mer caused knee hyperalgesia in WT mice, but not in Tlr2-null mice.
- Inhibition of 32-mer production or action prevented knee hyperalgesia in a murine OA model.
Conclusions:
- The aggrecan 32-mer fragment directly activates TLR2 on joint nociceptors.
- The 32-mer fragment is a key mediator in the development of osteoarthritis-associated joint pain.
Related Concept Videos
Habitat Fragmentation
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
G-protein Coupled Receptors
Pain
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Internal Receptors

